| Results from the ERA-EDTA Registry indicate a high mortality due to COVID-19 in dialysis patients and kidney transplant recipients across Europe KJ Jager, A Kramer, NC Chesnaye, C Couchoud, JE Sánchez-Álvarez, ... Kidney international 98 (6), 1540-1548, 2020 | 512 | 2020 |
| COVID-19-related mortality in kidney transplant and dialysis patients: results of the ERACODA collaboration LB Hilbrands, R Duivenvoorden, P Vart, CFM Franssen, MH Hemmelder, ... Nephrology Dialysis Transplantation 35 (11), 1973-1983, 2020 | 417 | 2020 |
| Antiproteinuric effect of blood-pressure-lowering agents: a meta-analysis of comparative trials RT Gansevoort, WJ Sluiter, MH Hemmelder, D De Zeeuw, PE De Jong Nephrology Dialysis Transplantation 10 (11), 1963-1974, 1995 | 411 | 1995 |
| Chronic kidney disease is a key risk factor for severe COVID-19: a call to action by the ERA-EDTA ERACODA Working Group Duivenvoorden Raphaël Franssen Casper FM Hemmelder ... Nephrology Dialysis Transplantation 36 (1), 87-94, 2021 | 359 | 2021 |
| Moderate dietary sodium restriction added to angiotensin converting enzyme inhibition compared with dual blockade in lowering proteinuria and blood pressure: randomised … MCJ Slagman, F Waanders, MH Hemmelder, AJ Woittiez, WMT Janssen, ... Bmj 343, 2011 | 326 | 2011 |
| The blunting of the antiproteinuric efficacy of ACE inhibition by high sodium intake can be restored by hydrochlorothiazide. H Buter, MH Hemmelder, G Navis, PE de Jong, D de Zeeuw Nephrology, dialysis, transplantation: official publication of the European …, 1998 | 287 | 1998 |
| The european renal association–european dialysis and transplant association (ERA-EDTA) registry annual report 2015: a summary A Kramer, M Pippias, M Noordzij, VS Stel, N Afentakis, PM Ambühl, ... Clinical kidney journal 11 (1), 108-122, 2018 | 254 | 2018 |
| The european renal association–european dialysis and transplant association (era-edta) registry annual report 2016: A summary A Kramer, M Pippias, M Noordzij, VS Stel, AM Andrusev, ... Clinical kidney journal 12 (5), 702-720, 2019 | 205 | 2019 |
| The changing trends and outcomes in renal replacement therapy: data from the ERA-EDTA Registry M Pippias, KJ Jager, A Kramer, T Leivestad, MB Sánchez, FJ Caskey, ... Nephrology Dialysis Transplantation 31 (5), 831-841, 2016 | 166 | 2016 |
| The European renal association–European dialysis and transplant association registry annual report 2014: a summary M Pippias, A Kramer, M Noordzij, N Afentakis, R Alonso de la Torre, ... Clinical kidney journal 10 (2), 154-169, 2017 | 151 | 2017 |
| Development of an international standard set of value-based outcome measures for patients with chronic kidney disease: a report of the International Consortium for Health … WR Verberne, Z Das-Gupta, AS Allegretti, HAJ Bart, W Van Biesen, ... American journal of kidney diseases 73 (3), 372-384, 2019 | 130 | 2019 |
| Renal replacement therapy in Europe: a summary of the 2013 ERA-EDTA Registry Annual Report with a focus on diabetes mellitus A Kramer, M Pippias, VS Stel, M Bonthuis, JM Abad Diez, N Afentakis, ... Clinical Kidney Journal 9 (3), 457-469, 2016 | 123 | 2016 |
| Effects of sodium restriction and hydrochlorothiazide on RAAS blockade efficacy in diabetic nephropathy: a randomised clinical trial AJ Kwakernaak, JA Krikken, SH Binnenmars, FW Visser, MH Hemmelder, ... The Lancet Diabetes & Endocrinology 2 (5), 385-395, 2014 | 115 | 2014 |
| The ERA-EDTA registry annual report 2017: a summary A Kramer, R Boenink, M Noordzij, JR Bosdriesz, VS Stel, P Beltrán, ... Clinical kidney journal 13 (4), 693-709, 2020 | 88 | 2020 |
| Routinely measuring symptom burden and health-related quality of life in dialysis patients: first results from the Dutch registry of patient-reported outcome measures EM van der Willik, MH Hemmelder, HAJ Bart, FJ van Ittersum, ... Clinical kidney journal 14 (6), 1535-1544, 2021 | 72 | 2021 |
| Healthcare costs of patients on different renal replacement modalities–analysis of Dutch health insurance claims data SM Mohnen, MJM van Oosten, J Los, MJH Leegte, KJ Jager, ... PLoS One 14 (8), e0220800, 2019 | 72 | 2019 |
| Patient‐reported outcome measures (PROMs): making sense of individual PROM scores and changes in PROM scores over time EM van der Willik, CB Terwee, WJW Bos, MH Hemmelder, KJ Jager, ... Nephrology 26 (5), 391-399, 2021 | 66 | 2021 |
| Patient-reported outcome measures: selection of a valid questionnaire for routine symptom assessment in patients with advanced chronic kidney disease–a four-phase mixed methods … EM van der Willik, Y Meuleman, K Prantl, G van Rijn, WJW Bos, ... BMC nephrology 20, 1-11, 2019 | 61 | 2019 |
| Antiproteinuric efficacy of verapamil in comparison to trandolapril in non-diabetic renal disease. MH Hemmelder, D de Zeeuw, PE de Jong Nephrology, dialysis, transplantation: official publication of the European …, 1999 | 49 | 1999 |
| Alternative strategies to increase the immunogenicity of COVID-19 vaccines in kidney transplant recipients not responding to two or three doses of an mRNA vaccine (RECOVAC): a … MML Kho, AL Messchendorp, SC Frölke, C Imhof, VJCH Koomen, ... The Lancet Infectious Diseases 23 (3), 307-319, 2023 | 47 | 2023 |
